These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 769668)

  • 61. Analysis of fluorescence quenching of ribosome-bound virginiamycin S.
    Di Giambattista M; Ide G; Engelborghs Y; Cocito C
    J Biol Chem; 1984 May; 259(10):6334-9. PubMed ID: 6427212
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Purification of the bacterial ribosome using chloramphenicol and erythromycin columns].
    LeGoffic F; Moreau N; Chevelot L; Langrene S; Siegrist S
    Biochimie; 1980; 62(1):69-77. PubMed ID: 6988016
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Erythromycin inhibition of 50S ribosomal subunit formation in Escherichia coli cells.
    Usary J; Champney WS
    Mol Microbiol; 2001 May; 40(4):951-62. PubMed ID: 11401702
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Three genes that affect Escherichia coli ribosomes.
    Apirion D
    J Mol Biol; 1967 Dec; 30(2):255-75. PubMed ID: 4870510
    [No Abstract]   [Full Text] [Related]  

  • 65. Functional consequences of binding macrolides to ribosomes.
    Menninger JR
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():23-34. PubMed ID: 3932309
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibition of polypeptide synthesis in cell-free systems by virginiamycin S and erythromycin. Evidence for a common mode of action of type B synergimycins and 14-membered macrolides.
    Chinali G; Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1988 Jan; 949(1):71-8. PubMed ID: 3120788
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic.
    Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1989 Sep; 1009(1):39-46. PubMed ID: 2506929
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interaction of the antibiotic sparsomycin with the ribosome.
    Lazaro E; San Felix A; van den Broek LA; Ottenheijm HC; Ballesta JP
    Antimicrob Agents Chemother; 1991 Jan; 35(1):10-3. PubMed ID: 2014963
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [14C]erythromycin-ribosome complex formation and non-enzymatic binding of aminoacyl-transfer RNA to ribosome-messenger RNA complex.
    Tanaka K; Teraoka H; Nagira T; Tamaki M
    Biochim Biophys Acta; 1966 Aug; 123(2):435-7. PubMed ID: 4961166
    [No Abstract]   [Full Text] [Related]  

  • 70. The mode of action of pleuromutilin derivatives. Location and properties of the pleuromutilin binding site on Escherichia coli ribosomes.
    Högenauer G
    Eur J Biochem; 1975 Mar; 52(1):93-8. PubMed ID: 1100373
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Binding of [3H]tetrahydroleucomycin A3 to Escherichia coli ribosomes and the effect of 3"-O-acyl derivatives of leucomycins on the binding.
    Omura S; Tanaka H; Inokoshi J; Sakakibara H; Fujiwara T
    J Antibiot (Tokyo); 1982 Apr; 35(4):491-6. PubMed ID: 7047480
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Binding of erythromycin to Escherichia coli ribosomes.
    Teraoka H
    J Antibiot (Tokyo); 1971 May; 24(5):302-9. PubMed ID: 4996450
    [No Abstract]   [Full Text] [Related]  

  • 73. Cross resistance of Escherichia coli B ribosomes to inhibition of the puromycin reaction by erythromycin, spiramycin and chloramphenicol.
    Cerná J; Rychlík I
    Biochim Biophys Acta; 1968 Apr; 157(2):436-8. PubMed ID: 4870247
    [No Abstract]   [Full Text] [Related]  

  • 74. Erythromycin-resistant mutant of Escherichia coli with altered ribosomal protein component.
    Tanaka K; Teraoka H; Tamaki M; Otaka E; Osawa S
    Science; 1968 Nov; 162(3853):576-8. PubMed ID: 4886608
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The molecular mechanism of peptide-mediated erythromycin resistance.
    Lovmar M; Nilsson K; Vimberg V; Tenson T; Nervall M; Ehrenberg M
    J Biol Chem; 2006 Mar; 281(10):6742-50. PubMed ID: 16410246
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro [3H]-erythromycin binding to Staphylococcus aureus.
    Barre J; Fournet MP; Zini R; Deforges L; Duval J; Tillement JP
    Biochem Pharmacol; 1986 Mar; 35(6):1001-4. PubMed ID: 3954790
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of erythromycin base and erythromycin esters on protein synthesis in vivo in Escherichia coli.
    Andersson SG; Kurland CG
    J Antimicrob Chemother; 1988 Nov; 22(5):605-12. PubMed ID: 3061998
    [TBL] [Abstract][Full Text] [Related]  

  • 78. tRNA binding to programmed ribosomes increases the ribosomal affinity for tuberactinomycin O.
    Yamada T; Teshima T; Shiba T; Nierhaus KH
    FEBS Lett; 1985 Jan; 179(1):37-40. PubMed ID: 2981179
    [TBL] [Abstract][Full Text] [Related]  

  • 79. AN EFFECT OF STREPTOMYCIN ON THE DISSOCIATION OF ESCHERICHIA COLI 70 S RIBOSOMES.
    Herzog A
    Biochem Biophys Res Commun; 1964 Mar; 15(2):172-6. PubMed ID: 26410912
    [No Abstract]   [Full Text] [Related]  

  • 80. Dissociation of proteins from Escherichia coli ribosomes after dimethylmaleic anhydride treatment. Effects of elongation factor G and antibiotics.
    Pintor-Toro JA; López-Rivas A; Hernández F; Palacián E
    FEBS Lett; 1981 Nov; 135(1):21-4. PubMed ID: 7032970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.